Snakebite envenoming is estimated to cause 95 000-125 000 deaths and up to 400 000 permanent injuries or disabilities worldwide on an annual basis. This serious health threat has been recognized by the World Health Organization, and snakebite envenoming is classified as a category A neglected tropical disease. 1 In May of 2018, the World Health Assembly adopted a resolution on snakebite envenoming, 2 thereby providing a mandate to develop a comprehensive plan to effectively control the burden of envenoming and reduce its debilitating impact. The multisectoral strategy that is required to achieve this will address socioeconomic, environmental, and healthcare challenges. Hoplocephalus snakes. [7] [8] [9] Also, the onset of VICC appears to proceed more rapidly following envenoming by Pseudonaja snake bites relative to those of Notechis snakes, 14 and MAHA only seems to occur following VICC-associated snakebites. and cancer, [18] [19] [20] [21] [22] and MVs may even impact progression of disease.
In their study, Enjeti and colleagues primarily studied MVs generated by platelets, red blood cells, and endothelial cells.
Compared to control subjects, platelet MVs were significantly higher in the blood of snakebite patients that did not suffer from MAHA, while paradoxically red blood cell-derived MV levels were
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